These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1324420)

  • 1. A point mutation (Ala229 to Thr) in the hinge domain of the c-erbA beta thyroid hormone receptor gene in a family with generalized thyroid hormone resistance.
    Behr M; Loos U
    Mol Endocrinol; 1992 Jul; 6(7):1119-26. PubMed ID: 1324420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.
    Usala SJ; Tennyson GE; Bale AE; Lash RW; Gesundheit N; Wondisford FE; Accili D; Hauser P; Weintraub BD
    J Clin Invest; 1990 Jan; 85(1):93-100. PubMed ID: 2153155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor.
    Usala SJ; Menke JB; Watson TL; Wondisford FE; Weintraub BD; Bérard J; Bradley WE; Ono S; Mueller OT; Bercu BB
    Mol Endocrinol; 1991 Mar; 5(3):327-35. PubMed ID: 1653889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new point mutation in the 3,5,3'-triiodothyronine-binding domain of the c-erbA beta thyroid hormone receptor is tightly linked to generalized thyroid hormone resistance.
    Usala SJ; Menke JB; Watson TL; Bérard WE; Bradley C; Bale AE; Lash RW; Weintraub BD
    J Clin Endocrinol Metab; 1991 Jan; 72(1):32-8. PubMed ID: 1846005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary resistance to thyroid hormone associated with a base mutation in the hormone-binding domain of the human 3,5,3'-triiodothyronine receptor-beta.
    Sasaki S; Nakamura H; Tagami T; Miyoshi Y; Nogimori T; Mitsuma T; Imura H
    J Clin Endocrinol Metab; 1993 May; 76(5):1254-8. PubMed ID: 8496318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain.
    Parrilla R; Mixson AJ; McPherson JA; McClaskey JH; Weintraub BD
    J Clin Invest; 1991 Dec; 88(6):2123-30. PubMed ID: 1661299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A point mutation in the 3,5,3'-triiodothyronine-binding domain of thyroid hormone receptor-beta associated with a family with generalized resistance to thyroid hormone.
    Shuto Y; Wakabayashi I; Amuro N; Minami S; Okazaki T
    J Clin Endocrinol Metab; 1992 Jul; 75(1):213-7. PubMed ID: 1619012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized resistance to thyroid hormone: identification of a novel c-erbA beta thyroid hormone receptor variant (Leu450) in a Japanese family and analysis of its secondary structure by the Chou and Fasman method.
    Hiramatsu R; Abe M; Morita M; Noguchi S; Suzuki T
    Jpn J Hum Genet; 1994 Dec; 39(4):365-77. PubMed ID: 7873749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An arginine to histidine mutation in codon 315 of the c-erbA beta thyroid hormone receptor in a kindred with generalized resistance to thyroid hormones results in a receptor with significant 3,5,3'-triiodothyronine binding activity.
    Cugini CD; Leidy JW; Chertow BS; Bérard J; Bradley WE; Menke JB; Hao EH; Usala SJ
    J Clin Endocrinol Metab; 1992 May; 74(5):1164-70. PubMed ID: 1314846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An arginine to histidine mutation in codon 311 of the C-erbA beta gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype.
    Geffner ME; Su F; Ross NS; Hershman JM; Van Dop C; Menke JB; Hao E; Stanzak RK; Eaton T; Samuels HH
    J Clin Invest; 1993 Feb; 91(2):538-46. PubMed ID: 8381821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel point mutation (R243Q) in exon 7 of the c-erbA beta thyroid hormone receptor gene in a family with resistance to thyroid hormone.
    Onigata K; Yagi H; Sakurai A; Nagashima T; Nomura Y; Nagashima K; Hashizume K; Morikawa A
    Thyroid; 1995 Oct; 5(5):355-8. PubMed ID: 8563471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodically hyperthyroid phenotype in thyroid hormone resistance is associated with mutation D322N in the thyroid hormone receptor beta gene: transcriptional properties of the mutant and the role of retinoid X receptor.
    Behr M; Loos U
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():111-6. PubMed ID: 8981016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of nineteen unrelated families with generalized resistance to thyroid hormone for known point mutations in the thyroid hormone receptor beta gene and the detection of a new mutation.
    Takeda K; Balzano S; Sakurai A; DeGroot LJ; Refetoff S
    J Clin Invest; 1991 Feb; 87(2):496-502. PubMed ID: 1991834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel mutations of thyroid hormone receptor beta gene in unrelated patients with resistance to thyroid hormone: two mutations of the same codon (H435L and H435Q) produce separate subtypes of resistance.
    Tsukaguchi H; Yoshimasa Y; Fujimoto K; Ishii H; Yamamoto T; Yoshimasa T; Yagura T; Takamatsu J
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3613-6. PubMed ID: 8530608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
    Piedrafita FJ; Ortiz MA; Pfahl M
    Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new point mutation (C446R) in the thyroid hormone receptor-beta gene of a family with resistance to thyroid hormone.
    Weiss RE; Chyna B; Duell PB; Hayashi Y; Sunthornthepvarakul T; Refetoff S
    J Clin Endocrinol Metab; 1994 May; 78(5):1253-6. PubMed ID: 8175986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive polymerase chain reaction quantitation of c-erbA beta 1, c-erbA alpha 1, and c-erbA alpha 2 messenger ribonucleic acid levels in normal, heterozygous, and homozygous fibroblasts of kindred S with thyroid hormone resistance.
    Klann RC; Torres B; Menke JB; Holbrook CT; Bercu BB; Usala SJ
    J Clin Endocrinol Metab; 1993 Oct; 77(4):969-75. PubMed ID: 8408473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent dimerization properties of mutant beta 1 thyroid hormone receptors are associated with different dominant negative activities.
    Hao E; Menke JB; Smith AM; Jones C; Geffner ME; Hershman JM; Wuerth JP; Samuels HH; Ways DK; Usala SJ
    Mol Endocrinol; 1994 Jul; 8(7):841-51. PubMed ID: 7984146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.
    Ng L; Forrest D; Haugen BR; Wood WM; Curran T
    Mol Endocrinol; 1995 Sep; 9(9):1202-13. PubMed ID: 7491112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unique C-termini of the thyroid hormone receptor variant, c-erbA alpha 2, and thyroid hormone receptor alpha 1 mediate different DNA-binding and heterodimerization properties.
    Katz D; Berrodin TJ; Lazar MA
    Mol Endocrinol; 1992 May; 6(5):805-14. PubMed ID: 1318505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.